AMT vs RLAY · P/E 31, rev $10.64B vs rev $3.4M
American Tower Corp (AMT) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the AMT and RLAY stock pages for the full models.
Not investment advice.